piper jaffray
-
Financial
Osiris Therapeutics’s Buy Rating Reiterated at Piper Jaffray (OSIR)
Piper Jaffray restated their buy rating on shares of Osiris Therapeutics (NASDAQ:OSIR) in a research notereleased on Thursday morning, Market Beat reports. Piper Jaffray currently…
Read More » -
MAKO Surgical (MAKO) Given New $35.00 Price Target by Piper Jaffray (PJC) Analysts.
Equities research analysts at Piper Jaffray (NYSE: PJC) boosted their price target on shares of MAKO Surgical (NASDAQ: MAKO) to $35.00…
Read More »